Head-to-head comparison
Bioverse vs Maves
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Bioverse (GoBioverse) offers compounded semaglutide and tirzepatide plus brand-name Ozempic, Wegovy, and Mounjaro.
From $129/mo (lowest dose rung) sema · From $399/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: No visible LegitScript or PCAB accreditation
FDAWarning letter issued to Bioverse, Inc. dba Bioverse in September 2025. See the FDA warning-letter database.
Desk Score
Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin.
$99/mo (first month only) sema · Verified July 2026
Marked down on: 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
Maves takes this head-to-head with the higher Desk Score, 82/100 (B−) against 49/100 (C) for Bioverse. Bioverse still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Bioverse
49/100
C
Maves
82/100
B−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Bioverse | Maves |
|---|---|---|
| Semaglutide | From $129/molowest dose rung$129/mo (starting dose, compounded) | $99/mofirst month only$99/mo (starting dose, first-month rate, compounded) |
| Tirzepatide | From $399/molowest dose rung$399/mo (starting dose, compounded) | Not listed on Maves's site (checked July 2026) |
| Coverage | Not listed on Bioverse's site (checked July 2026) | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Broad GLP-1 formulary with longevity add-ons. | $99 first-month semaglutide with men's-health and body-optimization framing. |
| Desk Score | 49/100C | 82/100B− |
The verdict
Desk pick — MavesMaves takes this head-to-head with the higher Desk Score, 82/100 (B−) against 49/100 (C) for Bioverse. Bioverse still holds its ground where its strengths line up with yours.
Choose Bioverse if…
Broad GLP-1 formulary with longevity add-ons.
From $129/mo (lowest dose rung) sema · From $399/mo (lowest dose rung) tirz
FDAWarning letter issued to Bioverse, Inc. dba Bioverse in September 2025. See the FDA warning-letter database.
Choose Maves if…
$99 first-month semaglutide with men's-health and body-optimization framing.
$99/mo (first month only) sema · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Bioverse · Maves.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Bioverse vs CoreAge Rx
- CoreAge Rx vs Maves
- Bioverse vs Effecty
- AgelessRx vs Maves
- AgelessRx vs Bioverse
- Maves vs PreventiveMD
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.